Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DARATUMUMAB Cause Product preparation issue? 13 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Product preparation issue have been filed in association with DARATUMUMAB (DARZALEX). This represents 0.1% of all adverse event reports for DARATUMUMAB.

13
Reports of Product preparation issue with DARATUMUMAB
0.1%
of all DARATUMUMAB reports
0
Deaths
0
Hospitalizations

How Dangerous Is Product preparation issue From DARATUMUMAB?

Of the 13 reports.

Is Product preparation issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DARATUMUMAB. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does DARATUMUMAB Cause?

Plasma cell myeloma (2,980) Infusion related reaction (2,557) Off label use (2,494) Pneumonia (1,450) Neutropenia (1,351) Drug ineffective (1,110) Thrombocytopenia (1,089) Death (1,088) Pyrexia (1,032) Dyspnoea (996)

What Other Drugs Cause Product preparation issue?

ONABOTULINUMTOXINA (677) COAGULATION FACTOR IX HUMAN\COAGULATION FACTOR VII HUMAN\COAGULATION FACTOR X HUMAN\PROTEIN C\PROTEIN S HUMAN\PROTHROMBIN (252) HUMAN C1-ESTERASE INHIBITOR (238) SOMATROPIN (200) INCOBOTULINUMTOXINA (174) STIRIPENTOL (129) TESAMORELIN (119) ABATACEPT (115) INFLIXIMAB (101) ABOBOTULINUMTOXINA (91)

Which DARATUMUMAB Alternatives Have Lower Product preparation issue Risk?

DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ DARATUMUMAB vs DARBEPOETIN ALFA DARATUMUMAB vs DARIDOREXANT DARATUMUMAB vs DARIFENACIN HYDROBROMIDE DARATUMUMAB vs DAROLUTAMIDE

Related Pages

DARATUMUMAB Full Profile All Product preparation issue Reports All Drugs Causing Product preparation issue DARATUMUMAB Demographics